Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alias Robotics develops the Robot Immune System (RIS), an endpoint protection platform that acts as an adaptive "immune system" for robots. RIS protects industrial, professional, and medical robots from cyberattacks by integrating firewalling, hardening, logging, AI-based threat detection, and visualization modules. The solution has been deployed in various sectors including healthcare robotics to ensure compliance with safety regulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alias Robotics.